With about 14,000 employees in more than 50 specialized clinical departments with almost 2,500 beds, about 80,000 patients in part-time and full-time inpatient treatment as well as 1,000,000 patients in ambulant treatment are medicated each year. By drawing a multidimensional map of therapy resistance, UNITE aims to develop concepts to predict and monitor treatment response and failure, and ultimately, to invent novel (combination) therapies for glioblastoma patients. The Postdoc position will be part of Work Package A03 “Deciphering Resistance Against Targeted Treatments- (Principal Investigators: Prof. Dr. med. In this project, preclinical models and cohort-derived tissues of patients with newly diagnosed and recurrent glioblastoma will be used to decipher molecular, cellular and imaging determinants of response and resistance to precision treatments in glioblastoma.
mehr